Pfizer holders could face tax hit in AstraZeneca deal By: MarketWatch May 09, 2014 at 06:12 AM EDT While Pfizer would cut its yearly tax bill if it buys rival AstraZeneca, thousands of Pfizer shareholders will face a tax hit if a deal goes through. Read More >> Related Stocks: Astrazeneca Plc ADR Macy's Pfizer